Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Low Level Laser Therapy for Body Contouring
This study has been completed.
Study NCT00738426   Information provided by Erchonia Medical, Inc.
First Received: August 18, 2008   Last Updated: August 19, 2008   History of Changes

August 18, 2008
August 19, 2008
October 2007
June 2008   (final data collection date for primary outcome measure)
Incidence of the reduction of at least 3.0 inches off their combined waist-hips-thighs circumference. [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00738426 on ClinicalTrials.gov Archive Site
Changes in weight, body mass index (BMI) and scores on the Body Shape Questionnaire (BSQ). [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
Same as current
 
Study of Low Level Laser Therapy for Body Contouring
A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS)on Body Contouring of the Waist, Hips and Thighs Clinical Study Protocol

The purpose of this study is to determine whether low level laser therapy is effective for body contouring of the waist, hips and thighs.

Weight loss and body contouring are large, constantly-growing fields of cosmetic surgery. According to the American Society of Plastic Surgeons (ASPS) statistics, more than 324,000 liposuction procedures, 233,000 eyelid surgeries and 114,000 facelift procedures were performed in 2004 in the United States alone. However, while the demand for body shaping procedures is constantly on the rise, so is the demand for such procedures to be performed more quickly, simply and most importantly, less invasively. Cosmetic surgery patients are no longer satisfied with procedures that require general anesthesia, pose a multitude of potentially serious risks and complications and that require several weeks of recovery time. Hence the growing popularity of non- to minimally-invasive cosmetic surgery procedures. In 2005, more than 7.5 million minimally-invasive cosmetic procedures were performed, a 35% increase from 2000. Consequently, patients and physicians alike are continually searching for non-invasive alternatives to traditional cosmetic procedures such as liposuction that are efficient, safe and effective.

 
Interventional
Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Body Contouring
Device: Erchonia ML Scanner (MLS)
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
72
July 2008
June 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • indicated for liposuction for the removal of localized deposits of adipose tissues that do not respond to diet and exercise; specifically in the areas of the waist, hips and bilateral thighs.
  • willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation.
  • willing and able to maintain regular diet and exercise regimen without during study participation.
  • 18 to 65 years.
  • Male or female.

Exclusion Criteria:

  • Body Mass Index (BMI) of 30 kg/m² or greater.
  • Diabetes dependent on insulin or oral hypoglycemic medications.
  • known cardiovascular disease.
  • cardiac surgeries, pacemakers.
  • excessive alcohol consumption.
  • prior surgical intervention for body sculpting/weight loss.
  • medical, physical, or other contraindications for body sculpting/weight loss.
  • current use of medication(s) known to affect weight levels and/or to cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent.
  • medical condition known to affect weight levels and/or to cause bloating or swelling.
  • diagnosis of, and/or taking medication for, irritable bowel syndrome.
  • active infection, wound or other external trauma to the areas to be treated with the laser.
  • pregnant, breast feeding, or planning pregnancy prior to study end.
  • serious mental health illness; psychiatric hospitalization in past two years.
  • developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
  • involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to weight-related and/or body shape issues.
  • participation in research in the past 90 days.
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00738426
Steven Shanks/President, Erchonia Medical, Inc.
BCL-001
Erchonia Medical, Inc.
 
Principal Investigator: Gregory C Roche, MD, FACS unaffiliated
Principal Investigator: Robert F Jackson, MD, FACS unaffiliated
Principal Investigator: Douglas D Dedo, MD, FACS unaffiliated
Erchonia Medical, Inc.
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP